Biotech

All Articles

Praxis epilepsy medication lessens seizures in period 2 litigation

.Praxis Accuracy Medicines has actually racked up an additional midphase win in epilepsy this year, ...

Three officers surrender as Dyne posts mixed information for DMD candidate

.After leaving a scientific hold numerous years back, Dyne Therapy has disclosed brand new stage 1/2...

Arrowhead fires off phase 3 data in uncommon metabolic illness in advance of market clash with Ionis

.Arrowhead Pharmaceuticals has revealed its give before a possible showdown with Ionis, releasing pe...

Pfizer, Valneva show lyme illness try reliable for second enhancer

.Pfizer and also Valneva may possess regarding 2 even more years to wait prior to they create the 1s...

Fierce Biotech Managing Editor Ayla Ellison Talks Patronize Michelle Benz on the Future of Biotech.

.Allow's dive into a discussion with Ayla Ellison, Intense Biotech Editor-in-Chief and Michelle Benz...

New information demonstrate how Bayer's asundexian neglected to prevent movements

.Bayer put on hold the period 3 test for its element XIa inhibitor asundexian late in 2015 after the...

Sanofi's tolebrutinib falls short 2 of 3 late-stage MS trials

.Sanofi is actually still set on taking its own multiple sclerosis (MS) med tolebrutinib to the FDA,...

Galapagos' stockpile as fund presents intent to form its progression

.Galapagos is coming under extra pressure coming from clients. Having constructed a 9.9% stake in Ga...

Cell- concentrated Sana scoops initial CSO-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our summary of notable management hirings, shootings and ...

Allist settles Jacobio $21M, landing function in Chinese KRAS ethnicity

.Shanghai Allist Pharmaceuticals has actually bought on its own a starring role in China's KRAS mark...